{
    "organizations": [],
    "uuid": "aab56a2a9cecbf242c0ef8e0a38a228b8863cfe2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aimmune-therapeutics-announces-pro/brief-aimmune-therapeutics-announces-proposed-public-offering-of-common-stock-idUSASB0C6JB",
    "ord_in_thread": 0,
    "title": "BRIEF-Aimmune Therapeutics Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Aimmune Therapeutics Inc:\n* AIMMUNE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* AIMMUNE THERAPEUTICS - COMMENCED OFFERING OF UP TO $150 MILLION SHARES\n* AIMMUNE - EXPECTS TO USE PROCEEDS FROM OFFERING TO FUND ONGOING CLINICAL DEVELOPMENT OF AR101 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-21T05:20:00.000+02:00",
    "crawled": "2018-02-21T21:09:29.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "aimmune",
        "therapeutic",
        "inc",
        "aimmune",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "aimmune",
        "therapeutic",
        "commenced",
        "offering",
        "million",
        "share",
        "aimmune",
        "expects",
        "use",
        "proceeds",
        "offering",
        "fund",
        "ongoing",
        "clinical",
        "development",
        "ar101",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}